Chemical Compound
Valsartan Imp. C (EP); Valsartan USP Related Compound B; Valsartan USP RC B; (2S)-2-[Butanoyl[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]amino]-3-methylbutanoic Acid; Valsartan Imp. C (EP), Valsartan Related Compound B (USP); Valsartan Related Compound B; Valsartan Impurity C
CAS Registry Number
952652-79-8
Primary record
Valsartan Imp. C (EP); Valsartan USP Related Compound B; Valsartan USP RC B; (2S)-2-[Butanoyl[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]amino]-3-methylbutanoic Acid; Valsartan Imp. C (EP), Valsartan Related Compound B (USP); Valsartan Related Compound B; Valsartan Impurity C
- 库存
- 717 克
- 纯度
- 99.5 %
- CAS
- 952652-79-8
化合物标识与属性
- CAS
- 952652-79-8
- PubChem CID
- 58153851
- SMILES
- CCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)[C@@H](C(C)C)C(=O)O
- Canonical SMILES
- CCCC(=O)N(Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1)[C@H](C(=O)O)C(C)C
名称与同义词
- Valsartan n-Propyl Impurity
- 952652-79-8
- Valsartan n-Propyl
- Valsartan EP Impurity C
- Despentanoyl butanoyl valsartan
- Valsartan related compound B
- UNII-4GS9P3LL2L
- 4GS9P3LL2L
- RefChem:132301
- (S)-2-(N-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)butyramido)-3-methylbutanoic acid
- C23H27N5O3
- MFCD19689078
- SCHEMBL684206
- Valsartan related compound B [USP]
- Valsartan specified impurity C
- DTXSID40241798
- Valsartan specified impurity C [EP]
- CTK8B8225
- DTXCID70164289
- Valsartan related compound B RS [USP]
- Valsartan related compound B (USP)
- 6389AC
- ANW-59704
- ARD000946
- SC1425
- ZINC65749016
- AKOS016003889
- VALSARTAN IMPURITY C [EP IMPURITY]
- ACN-026592
- CB11821
- CS-O-08394
- IO28664
- Valsartan related compound B RS (USP)
- AS-57083
- VALSARTAN RELATED COMPOUND B [USP-RS]
- VALSARTAN IMPURITY C (EP IMPURITY)
- AB0088238
- TC-148449
- FT-0675774
- ST24035906
- VALSARTAN RELATED COMPOUND B (USP-RS)
- VALSARTAN RELATED COMPOUND B [USP IMPURITY]
- Valsartan EP Impurity C; Valsartan USP Rc B
- A1194724
- VALSARTAN RELATED COMPOUND B (USP IMPURITY)
- (2S)-2-(Butanoyl((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)amino)-3-methylbutanoic acid
- (2S)-2-[butanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]-3-methylbutanoic acid
- L-Valine, N-(1-oxobutyl)-N-((2'-(2H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-
- Q27259571
- VALSARTAN N-PROPYL IMPURITY (REFERENCE GRADE)
- (2S)-3-METHYL-2-(N-{[2'-(1H-1,2,3,4-TETRAZOL-5-YL)-[1,1'-BIPHENYL]-4-YL]METHYL}BUTANAMIDO)BUTANOIC ACID
- B0179-407673
- (S)-2-(N-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)butyramido)-3-methylbutanoic acid
- [(S-N-BUTYRYL-N-([2'-(1H-TETRAZOLE-5-YL)BIPHEN-4-YL]METHYL)-VALINE)
- (S)-N-Butyryl-N-[[2'-(1H-tetrazole-5-yl)biphen-4-yl]methyl]-valine
- (2S)-2-[Butanoyl[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]amino]-3-methylbutanoic Acid
- N-(1-Oxobutyl)-N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-L-valine
- N-Butanoyl-N-{[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-L-valine
- Valsartan Related Compound B, United States Pharmacopeia (USP) Reference Standard
- (2S)-2-[butanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]-3-methyl-butanoic acid
- (2S)-3-methyl-2-[N-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)butanamido]butanoic acid
- (S)-2-(N-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)butyramido)-3-methylbutanoicacid
- (S)-N-Butyryl-N-{[2'-(1H-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine, 95% - 10MG 10mg
- Valsartan Imp. C (EP); Valsartan USP Related Compound B; Valsartan USP RC B; (2S)-2-[Butanoyl[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]amino]-3-methylbutanoic Acid; Valsartan Imp. C (EP), Valsartan Related Compound B (USP); Valsartan Related Compound B; Valsartan Impurity C
- Valsartan N-Butyryl Analog; (S)-2-(N-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)butyramido)-3-methylbutanoic acid
- Valsartan Related Compound B, Pharmaceutical Secondary Standard; Certified Reference Material